Concepedia

Darlene Gibbon

DG

20

Publications

982

Citations

16

H-Index

1994

Active since

Affiliations

Rutgers, The State University of New Jersey(Current)

Rutgers Cancer Institute

Johnson University

State University of New York

National Cancer Institute

Darlene Gibbon is an author at Rutgers, The State University of New Jersey specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

1994–2019

20

Publications

20

Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors

Anthony W. Tolcher, Wells A. Messersmith, Stanislaw M. Mikulski et al. · Journal of Clinical Oncology · 2012 · 277 citations · Full text

Papillary Serous and Clear Cell Type Lead to Poor Prognosis of Endometrial Carcinoma in Black Women

Roland Matthews, Juana Hutchinson-Colas, Mitchell Maiman et al. · Gynecologic Oncology · 1997 · 118 citations

, , +8

Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors

Antoinette R. Tan, Darlene Gibbon, Mark N. Stein et al. · Cancer Chemotherapy and Pharmacology · 2013 · 105 citations

, , +4

Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer.

Gary L. Goldberg, Darlene Gibbon, Harriet O. Smith et al. · Journal of Clinical Oncology · 1994 · 51 citations

The CD44 Receptor Is a Molecular Predictor of Survival in Ovarian Cancer

Inés Sancho-Torres, Clara Mesonero, Darlene Gibbon et al. · Medical Oncology · 2003 · 51 citations

, , +8

Rows per page

1–5 of 20